INTRODUCTION
Different studies have shown some effects of transplantation on quality of life (QoL). QoL improves post liver transplant [1] , primarily in areas affected by physical functioning with improvement in psychological function. QoL also may improve after renal transplant [2, 3] , pancreas-kidney transplant [4, 5] , heart and heart-lung transplant [6] , heart, liver and lung transplant [7] , and post solid organ (liver, heart, kidney and lung) transplant [8] . It is not known how much of the improvement in QoL is attributable to any rehabilitation process.
The literature provides some indications that physical function can be improved in transplantation with rehabilitation treatment. It is possible to find some data on outpatient rehabilitation post-transplant. Physical performance can be improved on an outpatient basis post liver transplant [9] , lung transplant [10] , kidney transplant [11, 12] , pancreas-kidney [13] transplant and cardiac transplant [14] [15] [16] [17] [18] .
On an inpatient basis, there are little data. There is, for instance, a report of a single case of complicated inpatient rehabilitation post liver transplant [19] . Providing occupational therapy services post-transplant in an acute hospital is effective in improving function [20] . The largest study of inpatient rehabilitation published to date reported on 55 patients [21] , all of whom were liver transplants. They noted significant functional gains, but warned of complications. Another study [22] of twelve patients, reported on inpatient rehabilitation stays post cardiac rehab, with improvements in their degree of independence measured by the Barthel Activities of Daily Living index. A study of inpatient rehabilitation [23] Organ transplant patients develop a number of impairments during the pre-transplant, and peri-transplant phases. Most patients are much deconditioned [24] , and some may be nutritionally depleted [25] , anaemic, in respiratory or in cardiac failure. They are likely to suffer some of the complications of bed rest [26, 27] . Complications such as neuropathy and myopathy are associated with ICU stays in general [28] [29] [30] [31] , and specifically in liver transplants [32] [33] [34] . Uremic patients [35] may have myopathies, and many patients may be taking some medications such as colchicine or cyclosporine [36] . Cognitive impairments may occur on the basis of the disease (e.g. organ failure such as liver [37] , heart or lung [38] ), treatment with some medications (even less toxic medications such as corticosteroids [39] ), or as a complication of cardio-pulmonary by-pass (at least during coronary artery by-pass grafting [40] ). Cognitive impairments from liver disease may improve post-transplant [34] .
Impairments such as those listed are in fact routinely treated in the inpatient rehabilitation setting in other patient groups. This raises the question of whether inpatient rehabilitation can improve physical function in the posttransplant group.
A rehabilitation program was established by a Rehab Hospital (RH) in partnership with a Multi-Organ Transplant (MOT) program in an acute hospital. A formal, written partnership was created between the RH and the MOT. The RH was the provider of choice for MOT patients requiring inpatient rehabilitation. Up to six rehab beds could be available for these patients. The RH had clear admission criteria and processed admission requests rapidly in order to clear the MOT beds expeditiously. Original diagnosis and type of transplanted solid organ were not considerations. The only real consideration was whether the patient had goals that could be achieved in an inpatient rehab program. The MOT provided medical support by offering education sessions to medical and pharmacy staff, and day to day support via telephone, pager, follow-up clinics and by telehealth. Both partners worked to convince the ambulance services to repatriate acutely ill patients from the RH directly to the MOT, when otherwise their policy was to take patients to the nearest emergency department. The MOT ensured that beds and/or resources would be available for repatriation if needed.
The purpose of this study was to report the outcomes of 173 post solid organ transplant patients who came to the inpatient rehab program, and reviewed the features of the unique partnership (RH-MOT) which allowed it to succeed.
METHODS
This was a retrospective observational cohort study of all solid organ transplant patients from the MOT (n = 173) consecutively admitted to the RH in the first four fiscal years after the creation of the partnership (April 1, 2004 to March 31, 2008) . The control cohort was the entire patient population admitted to the RH during this same time period (n = 9762). The RH had eight inpatient rehab programs-amputee, burn, cardiac, musculoskeletal, neurological, oncological, transplant, and trauma. Over half of the entire population of the RH consisted of postoperative orthopaedic patients, mostly total joint arthroplasties. No patients were excluded from the study.
Specific Rehabilitation Program for Organ Transplant Patients
There were no specific components of the rehabilitation program usually adjusted by patient diagnosis, or by type of organ transplanted. Nor in fact was the disease that caused the need for transplant considered unless the disease caused specific changes in Body Functions, Structure, Activities or Participation that required rehabilitation considerations. Each rehabilitation program was specifically tailored to the individual patient with their individual list of problems with Body Functions, Structure, Activities and Participation as identified by the patient and the rehabilitation team, in the context of which abilities were most needed by the patient. As noted in the introduction above, the most common problems were extreme fatigue, severe deconditioning, nutritional depletion, metabolic toxicity, myopathy, neuropathy, cognitive loss secondary to disease or its treatment, and depression. In fact, this list is more a list of problems of long standing, chronic, and severe illness than a list of problems with specific organs or specific diseases. As such, the rehabilitation program for the transplant patients had much in common with many of the other programs at the RH. The problems experienced by transplant program patients compared to those in the cardiac, severe trauma, severe medical illness, burn, and oncology programs usually had many more similarities than differences.
Medical complications included rejection of the transplanted organ, anemia, cardiac failure, respiratory failure and infections. Medical complications were sometimes treated in the RH, but more often in the MOT.
The electronic data collected was part of the routine operation of the RH. Basic demographic information, admission and discharge information, including the Functional Independence Measure (FIM ™ ) are routinely collected and entered into the RH electronic database.
The FIM ™ instrument was developed in 1983 by a national task force in the United States to meet a long standing need for an outcome measure that documents the severity of patient disability and outcomes of medical rehabilitation [41] . The FIM ™ instrument is the most widely used standardized functional outcome measure in medical rehabilitation. The FIM ™ instrument has been recognized as an indicator of burden of care and has the ability to predict the need for rehabilitation services [42] [43] [44] [45] [46] . The FIM ™ instrument consists of 18 items with 2 subscales: motor (13 items) and cognitive (5 items). Each item is given a rating of 1 -7, the lower the rating the more dependent, the higher the rating the more independent. The ratings are tallied up for a maximum total rating of 126 and a minimum rating of 18 [47] .
The FIM ™ instrument has demonstrated reliability and validity in a number of different patient populations (multiple sclerosis, stroke [43, 45, [48] [49] [50] , spinal cord injury [42, 51, 52] , traumatic brain injury [42, 46] , and in the burn population) [53] [54] [55] , as a general measure of functional independence [56] . The FIM ™ gain is the difference between the discharge and admission FIM ™ scores and higher values indicate greater functional independence during hospitalization. The FIM ™ efficiency is the FIM ™ gain divided by the length of stay, and measures rate of functional improvement [57] .
All planned discharges have a discharge FIM ™ rating on file. Planned discharges occur when all established goals are completed-either achieved or abandoned. Discharge FIM ™ rating is not measured if the rehab program is interrupted (i.e. an unplanned discharge). For reasons of mandated reporting, unplanned discharges are separated into discharges soon after admission (<3 days) and discharges after 3 days.
The RH Research Ethics Board approved the research protocol. The data was retrospectively analyzed for the two described cohorts. The outcomes of the organ transplant group were compared by fiscal year (2004, 2005, 2006, 2007, 2008) to determine if there were differences overtime. Chi-square and one sample t-tests were used for statistical analysis, with a p < 0.05 considered significant. Table 1 shows the demographics of the 173 organ transplant patients who underwent inpatient rehabilitation. The majority were men (56.6%), post liver (43.4%), followed by lung (24.9%), and organ transplants with more than 1 year post transplant (16.8%). Compared to the general rehabilitation population, transplant patients were more likely to be male (56.6% vs. 36.0%, p < 0.001) and younger (54.9 vs. 69.5 years, p < 0.001). Unplanned discharges soon after admission (transfers to acute care MOT within three days of rehab admission) were more likely to occur in transplants than the general rehabilitation population (5.2 % vs. 1.9%, p < 0.002). Readmission to an acute care facility after the first 3 days was greater for the transplant population (19.1% vs. 1.9%, p < 0.001). Transplant patients had longer mean length of stay (27 ± 19 vs. 20 ± 18 days, p < 0.001) and slightly lower FIM ™ efficiency scores (1.1 vs. 1.4, p < 0.001) than did the general rehabilitation population. Mean motor (13.1 vs. 20.4), cognitive (−4.9 vs. 0.5) and total FIM ™ (8.9 vs. 20.9) rating changes were significantly lower in the transplant population than the general rehabilitation population ( Table 2) .
RESULTS
Of the transplant patients who were not readmitted to Heart (%) 10 (5.8)
Heart-Lung (%) 3 (1.7)
Kidney (%) 3 (1.7)
Combined (%) 10 (5.8) an acute care hospital, 98.5% were able to successfully meet their rehabilitation goals and were discharged home directly from the RH, compared to 94.5% (p < 0.001) of the general rehab patients ( Table 2) .
Outcomes by Organ Transplant Group
Patients post-kidney transplant were significantly older (64 years), patients post-combined transplants (who had several organs transplanted in the same operation) had more immediate (<3 days) transfers to an acute hospital (10%), and a higher rate of readmission to an acute hospital after the first 3 days (20%), and patients who received a heart-lung transplant had greater FIM ™ efficiency (1.2) than the other organ transplant groups (Table 3).
Outcomes of Organ Transplant Group by Year
The greater improvements in outcomes were seen in last two years of the study. In 2007, there were more transplant patients admitted to the RH (61%, 35.3%). and there was a significantly reduced waiting time for RH admission (1.6 days). In 2008, there were no immediate (<3 days) transfers to an acute hospital, no readmission to an acute hospital after the first 3 days, and all patients met the rehab goals and were discharged to their homes ( Table 4) . 
Outcomes of the Partnership RH-MOT
The waiting time from the moment an organ transplant patient was ready for discharge from the MOT and admission to the RH was on average 2.4 days in April 2004, compared to an average of 1.6 days in 2007, representing a 66.7% reduction of waiting time to be transferred to the alternative level of care (ALC), in this case the RH. This reduction represented that more beds at the MOT were available for new solid organ transplant patients, improving bed utilization at the MOT.
DISCUSSION
Evaluating the, outcomes of 173 patients over four years in our RH program, we found a number of statistically significant differences between the outcomes of transplant rehab patients and general rehab patients. Transplant rehab patients were younger, had a longer length of stay, decreased FIM ™ efficiency, and reduced FIM ™ gain, compared to general rehab patients. But a higher proportion of transplant patients who were not readmitted to an acute care hospital went back into their home settings, compared to general rehab patients. One could also consider that over half of the total general rehabilitation patients were admitted to the musculoskeletal program. These consisted mostly of postoperative total joint arthroplasties who required a short length of stay and had a higher FIM ™ efficiency. However, even including those less complex musculoskeletal patients, the comparable transplant rehab outcomes are acceptable. Patients post-combined transplants had more immediate (<3 days) transfers to an acute hospital, and a higher rate of readmission to an acute hospital after the first 3 days, and patients who received a heart-lung transplant had greater FIM ™ efficiency than the other organ transplant groups. Overall, these results are convincing to demonstrate that an inpatient rehab program, assuming identified achievable rehab goals, can achieve acceptable outcomes in a manner that is as effective and efficient as the other programs in the RH.
There are however very significant differences between transplant rehab patients and other rehab patients in one area-unplanned discharges. Within the first three days, the rate of sending patients back to the acute hospital is almost three times higher in transplant patients. During the rest of their admission, transplant rehab patients were about ten times more likely to be sent to the acute hospital (19.1%) than were general rehab patients (1.9%). This is comparable to the rates reported elsewhere for transplant rehab (15% [21] ), or even transfer rates for a similar medically fragile and complex rehab group-oncology patients (21% [58] , 35% [59] ).
The partnership program between the RH and the MOT was established for two reasons. One was to improve organ transplant patients physical functioning, which is discussed above, and the other reason was regarding the logistics of the health care of these patients.
Regarding logistics, there are clear advantages to sending patients post-transplant to an inpatient rehabilitation program. The efficiency is increased because more beds in the transplant unit are cleared faster to be available for new organ transplant patients. Post-transplant patients no longer recuperate in high-cost transplant program beds in the MOT program (approximately CAN $700 per day, not including costs for housekeeping, dietary, allied health services, corporate overhead, lab & diagnostic testing). The rehabilitation is better in a rehab unit at lower cost (approximately CAN $594 per day, including direct and indirect costs), because the unit is appropriately staffed for rehab, has appropriate expertise, and has the equipment and space necessary for rehab. The rehab program focuses on maximum efficiency in recovery of function, meeting goals regarding safety, activities of daily living (both basic and instrumental), mobility, strength, endurance etc. The RH-MOT program has been a success in logistics, in helping patients to move along the continuum of care while remaining in the setting most appropriate to their needs at any given moment.
Therefore, there exists a patient group (post-operative organ transplants) for whom the acute hospital does not meet their needs well. There exist rehabilitation programs which can improve their impairments efficiently and cost effectively. Why do most transplant patients stay in acute hospital beds until discharge, following which some outpatient rehabilitation may or may not be instituted? There are a number of possible reasons. One might be that inpatient rehabilitation is just not part of the culture of the transplant team. This was answered by our partnership process, because the signed agreement served as an indicator of a cultural change, and focussed the communication strategy RH-MOT. A second reason might be that rehabilitation facilities are not comfortable with the complexity and possible instability of these patients and just do not routinely accept them. Again, the RH-MOT partnership was the answer to this. The MOT promised to maintain their medical accountability for these patients during complications, and they did in fact readmit sick patients as needed. A third reason might be that the rehab hospital might feel that they are unfamiliar with transplant impairments and treatment programs for them. With our partnership, the RH developed a formal program, and has acquired considerable expertise. It turns out that most of the impairments are not specific to the transplant patients. Nevertheless, this is now a high profile program for the RH. A fourth reason might be that the costs of converting RH beds to treat complex transplant patients might increase the costs of running each bed without necessarily having the ability to recoup those costs. This could be a significant disincentive in the Canadian health care system with a government funded hospital global budget model (where hospitals receive a fixed amount of money for operating costs, based upon historic experience [60] ), in particular the pharmacy budget would suffer a major impact. This would be a weaker disincentive in a case-costing funding model where a fee-for-service payment is billed to payers by the institutions [60] . A fifth reason might be that the initial barriers for the RH to overcome are large, and the initial cost of entry is high-essential factors include a minimum volume of cohorted patients, a team with identified members who acquire expertise, and aggressive RH medical treatment partnered with a full Transplant service backup-a large investment for the RH.
The last reason is that there may have been insufficient published literature to date to persuasively demonstrate that a rehab program will accomplish valued outcomes. Our data supports the pre-existing publications, and convincingly shows that transplant patients, regardless of organ group, improve their function at a rate and to an extent similar to other complex rehabilitation patient groups.
Study Limitations
While our results are substantial, one should consider the following: this is a retrospective study, which limits certain aspects of information gathering like patients' data, which depends on the accuracy of electronic data entry and the correct rehabilitation patient group (RPG) coding of these inpatients as organ transplant patients. Notably, the current study was conducted in Canada's only dedicated organ transplant rehabilitation program. Consequently, these results may not be representative of the general organ transplant population.
CONCLUSIONS
A written partnership agreement between a high volume multi-organ transplant service and a specialized rehabilitation hospital produced a program that over four years cleared 173 acute transplant beds expeditiously. The transplant patients had a significantly longer length of stay, decreased FIM ™ efficiency, larger FIM ™ gain, and a higher proportion of them went back into their home settings, compared to general rehabilitation patients. Although statistically significant, these results were not clinically significant because they all remain within the expected range of outcomes that would justify a course of rehabilitation. The rehab program improved patient function (as measured by FIM ™ efficiency) at an acceptable rate (1.1 vs. 1.4) compared to the general rehabilitation population in the same rehabilitation hospital (of whom close to half were short stay orthopaedic patients). It is known that for medically very complex patients (e.g., oncology patients), there will be a high rate of transfer back to acute hospital for treatment of complications and intercurrent illness, and this is as true for organ transplant patients in our study. There were greater outcome improvements in organ transplant patients during the last two years of the study (2007 and 2008) . We are planning to conduct a larger retrospective study where we will compare the functional outcomes of patients admitted to the RH organ transplant program with those of organ transplant patients who are not admitted to the RH program, matched by age, gender, and severity of physical function measured by the FIM ™ ratings. We will also stratify the patients in three comparison groups: the organ transplants, the orthopaedic patients, and the other groups in rehab. In addition, we will compare the rehabilitation outcomes of transplant patients by the organ transplanted to determine if their outcomes are the same or different.
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